References
- Yazaki H, Goto N, Uchida K, et al. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: p. jiroveci is contagious to the susceptible host. Transplantation. 2009;88(3):380–385.
- Gianella S, Haeberli L, Joos B, et al. Molecular evidence of interhuman transmission in an outbreak of Pneumocystis jirovecii pneumonia among renal transplant recipients. Transpl Infect Dis. 2010;12(1):1–10. .
- Iriart X, Challan Belval T, Fillaux J, et al. Risk factors of pneumocystis pneumonia in solid organ recipients in the era of the common use of posttransplantation prophylaxis. Am J Transplant. 2015;15(1):190–199. .
- Goto N, Oka S. Pneumocystis jirovecii pneumonia in kidney transplantation. Transpl Infect Dis. 2011;13(6):551–558.
- Thomas S, Turtle L, Imran M, et al. Outbreak of Pneumocystis Jirovecii Pneumonia in a British Renal Transplant Centre: evidence for human to human transmission, or an environmental source of infection: category: lesson in microbiology & infection control. Journal of Infection. 2011;63:e25–e26.
- Mulpuru S, Knoll G, Weir C, et al. Pneumocystis pneumonia outbreak among renal transplant recipients at a North American transplant center: risk factors and implications for infection control. Am J Infect Control. 2016;44(4):425–431.
- Le Gal S, Toubas D, Totet A, et al. Pneumocystis infection outbreaks in organ transplantation units in France: a nation-wide survey. Clin Infect Dis. 2020;70(10):2216–2220.
- Fishman JA. Pneumocystis jiroveci. Semin Respir Crit Care Med. 2020;41(1):141–157.
- Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019;14(1):319–338.
- Simner PJ, Miller S, Carroll KC. Understanding the promises and hurdles of metagenomic next-generation sequencing as a diagnostic tool for infectious diseases. Clin Infect Dis. 2018;66(5):778–788.
- Wilson MR, O’Donovan BD, Gelfand JM, et al. Chronic meningitis investigated via metagenomic next-generation sequencing. JAMA Neurol. 2018;75(8):947–955.
- Wang J, Han Y, Feng J. Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis. BMC Pulm Med. 2019;19(1):252.
- Chen J, He T, Li X, et al. Metagenomic next-generation sequencing in diagnosis of a case of pneumocystis jirovecii pneumonia in a kidney transplant recipient and literature review. Infect Drug Resist. 2020;13:2829–2836.
- Miao Q, Ma Y, Wang Q, et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis. 2018;67(suppl_2):S231–s240.
- Kim JE, Han A, Lee H, et al. Impact of Pneumocystis jirovecii pneumonia on kidney transplant outcome. BMC Nephrol. 2019;20:212.
- Alanio A, Hauser PM, Lagrou K, et al. ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016;71(9):2386–2396.
- Esteves F, Calé SS, Badura R, et al. Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers. Clin Microbiol Infect. 2015;21(4):379.e1-10.
- Camargo JF, Ahmed AA, Lindner MS, et al. Next-generation sequencing of microbial cell-free DNA for rapid noninvasive diagnosis of infectious diseases in immunocompromised hosts. F1000Res. 2019;8:1194.
- Radisic M, Lattes R, Chapman JF, et al. Risk factors for Pneumocystis carinii pneumonia in kidney transplant recipients: a case-control study. Transpl Infect Dis. 2003;5(2):84–93.
- Garg N, Jorgenson M, Descourouez J, et al. Pneumocystis jiroveci pneumonia in kidney and simultaneous pancreas kidney transplant recipients in the present era of routine post-transplant prophylaxis: risk factors and outcomes. BMC Nephrol. 2018;19(1):332.
- Faure E, Lionet A, Kipnis E, et al. Risk factors for Pneumocystis pneumonia after the first 6 months following renal transplantation. Transpl Infect Dis. 2017;19(5):19.
- Park SY, Jung JH, Kwon H, et al. Epidemiology and risk factors associated with Pneumocystis jirovecii pneumonia in kidney transplant recipients after 6-month trimethoprim-sulfamethoxazole prophylaxis: a case-control study. Transpl Infect Dis. 2020;22(2):e13245.
- Hosseini-Moghaddam SM, Shokoohi M, Singh G, et al. A multicenter case-control study of the effect of acute rejection and cytomegalovirus infection on pneumocystis pneumonia in solid organ transplant recipients. Clin Infect Dis. 2019;68(8):1320–1326.
- Yu Y, Yang H, Yu X, et al. Critical appraisal of the quality and content of clinical practice guidelines for pneumocystis jiroveci pneumonia (PJP) prophylaxis using the AGREE II instrument. J Clin Pharm Ther. 2020;45(6):1325–1333.
- Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: a summary. Kidney Int. 2010;77(4):299–311.
- Baker RJ, Mark PB, Patel RK, et al. Renal association clinical practice guideline in post-operative care in the kidney transplant recipient. BMC Nephrol. 2017;18(1):174.
- Martin SI, Fishman JA. Pneumocystis pneumonia in solid organ transplantation. Am J Transplant. 2013;13(Suppl 4):272–279.
- Tu GW, Ju MJ, Xu M, et al. Combination of caspofungin and low-dose trimethoprim/sulfamethoxazole for the treatment of severe Pneumocystis jirovecii pneumonia in renal transplant recipients. Nephrology (Carlton). 2013;18(11):736–742.
- Lobo ML, Esteves F, De Sousa B, et al. Therapeutic potential of caspofungin combined with trimethoprim-sulfamethoxazole for pneumocystis pneumonia: a pilot study in mice. PLoS One. 2013;8(8):e70619.
- Jin F, Liu XH, Chen WC, et al. High initial (1, 3) Beta-d-Glucan concentration may be a predictor of satisfactory response of c aspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe Pneumocystis jirovecii pneumonia. Int J Infect Dis. 2019;88:141–148.
- Chatzikyrkou C, Clajus C, Haubitz M, et al. Hypercalcemia and pneumocystis Pneumonia after kidney transplantation: report of an exceptional case and literature review. Transpl Infect Dis. 2011; 13:496–500.
- Xie D, Hu K, Xian Y, et al. A life-threatening duodenal ulcer hemorrhage due to previously unknown primary hyperparathyroidism. Gastroenterol Rep (Oxf). 2018;6(3):231–233.
- Ali HS, Hassan IF, George S Extra corporeal membrane oxygenation to facilitate lung protective ventilation and prevent ventilator-induced lung injury in severe Pneumocystis pneumonia with pneumomediastinum: a case report and short literature review. BMC Pulm Med. 2016; 16:52.
- Cheng WL, Ko WC, Lee NY, et al. Pneumomediastinum in patients with AIDS: a case report and literature review. Int J Infect Dis. 2014; 22:31–34.
- Cho JY, Kim DM, Kwon YE, et al. Newly formed cystic lesions for the development of pneumomediastinum in Pneumocystis jirovecii pneumonia. BMC Infect Dis. 2009;9(1):171.